Introduction to cancer genetic susceptibility syndromes
نویسندگان
چکیده
منابع مشابه
Genetic susceptibility to lung cancer.
Lung cancer is a highly environmental disease, but cancer researchers have long been interested in investigating genetic susceptibility to lung cancer. This paper is a historical review and provides updated perspectives on lung cancer susceptibility research. The recent introduction of easier genotyping methods and the availability of an almost complete human genome database facilitated the ass...
متن کاملGenetic polymorphism of N142D GSTO2 and susceptibility to breast cancer: a meta-analysis
To establish a comprehensive picture of the relationship between glutathione S-transferase omega 2 (GSTO2; MIM: 612314) gene N142D variant (rs. 156697) and breast cancer risk, the present meta-analysis was carried out. Studies published up to July 2012 with information about GSTO2 polymorphism and breast cancer risk were identified using several electronic databases. We identified 4 eligible st...
متن کاملspecial attention to genetic counseling regarding familial cancer syndromes during pregnancy (letter to editor)
introduction: performing research on (human) volunteers may involve useful or harmful effects. to preserve the volunteers' dignity, numerous world associations have issued declarations such as nuremberg's, helsinki's, belmont's report, etc. one of the four ethical principles in research is respecting volunteers' rights and the most obvious aspect of this respect materializes in obtaining the vo...
متن کاملInherited cancer susceptibility syndromes in paediatric practice.
Over the last decade there have been rapid advances in our knowledge about the molecular basis of many inherited disorders. Molecular testing is now available for many conditions and may assist in the management of the individual and their extended family. One area where the use of genetic testing has expanded rapidly is in the area of hereditary cancer, particularly in relation to hereditary b...
متن کاملGenetic susceptibility to aggressive prostate cancer.
In 2006, f234,460 men in the U.S. will be diagnosed with prostate cancer, and >27,000 deaths will be attributed to the disease (1). There is substantial phenotypic variability among cases and the disease incidence varies by age, race, and family history. In the U.S., f70% of all cases are z65 years at diagnosis, and the median age at diagnosis is 68 years (2). Several types of epidemiologic stu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hematology
سال: 2016
ISSN: 1520-4391,1520-4383
DOI: 10.1182/asheducation-2016.1.293